Mitogen-activated Tasmanian devil blood mononuclear cells kill devil facial tumour disease cells
Gabriella K Brown, Cesar Tovar, Anne A Cooray, Alexandre Kreiss, Jocelyn Darby, James M Murphy, Lynn M Corcoran, Silvana S Bettiol, A Bruce Lyons, Gregory M Woods
Immunology & Cell Biology | NATURE PUBLISHING GROUP | Published : 2016
Awarded by Australian Research Council
Awarded by National Health and Medical Research Council
Awarded by NHMRC IRIISS
This work was supported by funding from the Australian Research Council (LP0989727, LP130100218 and DP130100715), Dr Eric Guiler Tasmanian devil research grants, the Mazda Foundation, through fellowships from the National Health and Medical Research Council to LMC (637306) and the Australian Research Council to JMM (FT100100100). JMM and LMC acknowledge support from the Victorian State Government Operational Infrastructure Support Scheme and NHMRC IRIISS grant (9000220). We thank Tony Papenfuss and Sam Young for contributions to recombinant devil IL-2 expression construct design and preparation. We also thank Anne-Maree Pearse and Kate Swift of DPIPWE for the provision of DFT1 cell lines. We acknowledge the support of the Save the Tasmanian Devil Program. We are grateful for the expert care of the Tasmanian devils by the DPIPWE devil keepers and Ginny Ralph.